找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Immunotherapy; Aung Naing,Joud Hajjar Book 20203rd edition The Editor(s) (if applicable) and The Author(s), under exclusive license to Spr

[复制链接]
楼主: CHAFF
发表于 2025-3-28 16:35:15 | 显示全部楼层
Immunotherapy for Melanoma,ery limited treatment options were available for patients with metastatic melanoma. However, recent breakthroughs have brought new hopes for patients and providers. While targeted therapy with BRAF and MEK inhibitors represents an important cornerstone in the treatment of metastatic melanoma, this c
发表于 2025-3-28 18:43:55 | 显示全部楼层
Immunotherapy in Lung Cancer: From a Minor God to the Olympus,e the immune system, also known as immunotherapy. Blocking immune checkpoints has emerged as an effective strategy with unprecedented results in several solid tumors, including lung cancer. Since 2012 when PD(L)-1 inhibitors showed first clinical signals of activity in lung cancer, immune checkpoint
发表于 2025-3-29 01:08:08 | 显示全部楼层
发表于 2025-3-29 03:52:12 | 显示全部楼层
发表于 2025-3-29 09:46:04 | 显示全部楼层
发表于 2025-3-29 11:59:48 | 显示全部楼层
发表于 2025-3-29 16:25:09 | 显示全部楼层
发表于 2025-3-29 22:54:00 | 显示全部楼层
Skin Reactions to Immune Checkpoint Inhibitors,ubstantial rate of cutaneous reactions, has left many clinicians without sufficient familiarity to diagnose and treat cutaneous AEs. Pruritus and rash are among the top five immune-related AEs reported in clinical trials for this class of therapy. Incidence varies between 35 and 50% for cutaneous AE
发表于 2025-3-30 03:03:42 | 显示全部楼层
发表于 2025-3-30 07:49:42 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-15 12:51
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表